These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1384 related articles for article (PubMed ID: 27433846)
61. Frequency of Pathogenic Germline Mutations in Early and Late Onset Familial Breast Cancer Patients Using Multi-Gene Panel Sequencing: An Egyptian Study. Nassar A; Zekri AN; Kamel MM; Elberry MH; Lotfy MM; Seadawy MG; Hassan ZK; Soliman HK; Lymona AM; Youssef ASE Genes (Basel); 2022 Dec; 14(1):. PubMed ID: 36672847 [TBL] [Abstract][Full Text] [Related]
62. The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. The Cancer Research Campaign/British Prostate Group United Kingdom Familial Prostate Cancer Study Collaborators. Gayther SA; de Foy KA; Harrington P; Pharoah P; Dunsmuir WD; Edwards SM; Gillett C; Ardern-Jones A; Dearnaley DP; Easton DF; Ford D; Shearer RJ; Kirby RS; Dowe AL; Kelly J; Stratton MR; Ponder BA; Barnes D; Eeles RA Cancer Res; 2000 Aug; 60(16):4513-8. PubMed ID: 10969800 [TBL] [Abstract][Full Text] [Related]
63. Prevalence of Germline Mutations in Genes Engaged in DNA Damage Repair by Homologous Recombination in Patients with Triple-Negative and Hereditary Non-Triple-Negative Breast Cancers. Domagala P; Jakubowska A; Jaworska-Bieniek K; Kaczmarek K; Durda K; Kurlapska A; Cybulski C; Lubinski J PLoS One; 2015; 10(6):e0130393. PubMed ID: 26083025 [TBL] [Abstract][Full Text] [Related]
64. The association between germline BRCA2 variants and sensitivity to platinum-based chemotherapy among men with metastatic prostate cancer. Pomerantz MM; Spisák S; Jia L; Cronin AM; Csabai I; Ledet E; Sartor AO; Rainville I; O'Connor EP; Herbert ZT; Szállási Z; Oh WK; Kantoff PW; Garber JE; Schrag D; Kibel AS; Freedman ML Cancer; 2017 Sep; 123(18):3532-3539. PubMed ID: 28608931 [TBL] [Abstract][Full Text] [Related]
65. Germline investigation in male breast cancer of DNA repair genes by next-generation sequencing. Scarpitta R; Zanna I; Aretini P; Gambino G; Scatena C; Mei B; Ghilli M; Rossetti E; Roncella M; Congregati C; Bonci F; Naccarato AG; Palli D; Caligo MA Breast Cancer Res Treat; 2019 Dec; 178(3):557-564. PubMed ID: 31512090 [TBL] [Abstract][Full Text] [Related]
66. Germline and Somatic Mutations in Prostate Cancer for the Clinician. Cheng HH; Sokolova AO; Schaeffer EM; Small EJ; Higano CS J Natl Compr Canc Netw; 2019 May; 17(5):515-521. PubMed ID: 31085765 [TBL] [Abstract][Full Text] [Related]
67. Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer. Yurgelun MB; Kulke MH; Fuchs CS; Allen BA; Uno H; Hornick JL; Ukaegbu CI; Brais LK; McNamara PG; Mayer RJ; Schrag D; Meyerhardt JA; Ng K; Kidd J; Singh N; Hartman AR; Wenstrup RJ; Syngal S J Clin Oncol; 2017 Apr; 35(10):1086-1095. PubMed ID: 28135145 [TBL] [Abstract][Full Text] [Related]
68. A comprehensive evaluation of CHEK2 germline mutations in men with prostate cancer. Wu Y; Yu H; Zheng SL; Na R; Mamawala M; Landis T; Wiley K; Petkewicz J; Shah S; Shi Z; Novakovic K; McGuire M; Brendler CB; Ding Q; Helfand BT; Carter HB; Cooney KA; Isaacs WB; Xu J Prostate; 2018 Jun; 78(8):607-615. PubMed ID: 29520813 [TBL] [Abstract][Full Text] [Related]
69. Germline Mutations in DNA Repair Genes in Patients With Metastatic Castration-resistant Prostate Cancer. Holeckova K; Baluchova K; Hives M; Musak L; Kliment J; Skerenova M In Vivo; 2020; 34(4):1773-1778. PubMed ID: 32606146 [TBL] [Abstract][Full Text] [Related]
70. Outcomes of universal germline testing for men with prostate cancer in an Australian tertiary center. Crumbaker M; Wong J; Joshua AM; Spigelman AD Asia Pac J Clin Oncol; 2019 Aug; 15(4):257-261. PubMed ID: 31012270 [TBL] [Abstract][Full Text] [Related]
71. Comparison of BRCA versus non-BRCA germline mutations and associated somatic mutation profiles in patients with unselected breast cancer. Chen B; Zhang G; Li X; Ren C; Wang Y; Li K; Mok H; Cao L; Wen L; Jia M; Li C; Guo L; Wei G; Lin J; Li Y; Zhang Y; Han-Zhang H; Liu J; Lizaso A; Liao N Aging (Albany NY); 2020 Feb; 12(4):3140-3155. PubMed ID: 32091409 [TBL] [Abstract][Full Text] [Related]
72. Homologous recombination repair gene mutations in Chinese localized and locally advanced prostate cancer patients. Jiang X; Hu X; Gu Y; Li Y; Jin M; Zhao H; Gao R; Huang Z; Lu J Pathol Res Pract; 2021 Aug; 224():153507. PubMed ID: 34102435 [TBL] [Abstract][Full Text] [Related]
73. Prevalence of DNA repair gene mutations in localized prostate cancer according to clinical and pathologic features: association of Gleason score and tumor stage. Marshall CH; Fu W; Wang H; Baras AS; Lotan TL; Antonarakis ES Prostate Cancer Prostatic Dis; 2019 Mar; 22(1):59-65. PubMed ID: 30171229 [TBL] [Abstract][Full Text] [Related]
74. Efficacy of systemic therapies in men with metastatic castration resistant prostate cancer harboring germline ATM versus BRCA2 mutations. Sokolova AO; Marshall CH; Lozano R; Gulati R; Ledet EM; De Sarkar N; Grivas P; Higano CS; Montgomery B; Nelson PS; Olmos D; Sokolov V; Schweizer MT; Yezefski TA; Yu EY; Paller CJ; Sartor O; Castro E; Antonarakis ES; Cheng HH Prostate; 2021 Dec; 81(16):1382-1389. PubMed ID: 34516663 [TBL] [Abstract][Full Text] [Related]
76. Germline mutations in DNA repair genes are associated with bladder cancer risk and unfavourable prognosis. Na R; Wu Y; Jiang G; Yu H; Lin X; Wang M; Conran CA; Fantus RJ; Zhang N; Liu S; Helfand BT; Zheng SL; Isaacs WB; Ding Q; Shen Z; Xu J BJU Int; 2018 Nov; 122(5):808-813. PubMed ID: 29727914 [TBL] [Abstract][Full Text] [Related]
77. BRCAness and prostate cancer: diagnostic and therapeutic considerations. Dhawan M; Ryan CJ Prostate Cancer Prostatic Dis; 2018 Nov; 21(4):488-498. PubMed ID: 30131605 [TBL] [Abstract][Full Text] [Related]
78. Gene panel testing of 5589 BRCA1/2-negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer. Hauke J; Horvath J; Groß E; Gehrig A; Honisch E; Hackmann K; Schmidt G; Arnold N; Faust U; Sutter C; Hentschel J; Wang-Gohrke S; Smogavec M; Weber BHF; Weber-Lassalle N; Weber-Lassalle K; Borde J; Ernst C; Altmüller J; Volk AE; Thiele H; Hübbel V; Nürnberg P; Keupp K; Versmold B; Pohl E; Kubisch C; Grill S; Paul V; Herold N; Lichey N; Rhiem K; Ditsch N; Ruckert C; Wappenschmidt B; Auber B; Rump A; Niederacher D; Haaf T; Ramser J; Dworniczak B; Engel C; Meindl A; Schmutzler RK; Hahnen E Cancer Med; 2018 Apr; 7(4):1349-1358. PubMed ID: 29522266 [TBL] [Abstract][Full Text] [Related]
79. Germline mutations in DNA repair genes predispose asbestos-exposed patients to malignant pleural mesothelioma. Betti M; Casalone E; Ferrante D; Aspesi A; Morleo G; Biasi A; Sculco M; Mancuso G; Guarrera S; Righi L; Grosso F; Libener R; Pavesi M; Mariani N; Casadio C; Boldorini R; Mirabelli D; Pasini B; Magnani C; Matullo G; Dianzani I Cancer Lett; 2017 Oct; 405():38-45. PubMed ID: 28687356 [TBL] [Abstract][Full Text] [Related]
80. Germline Testing in Prostate Cancer: When and Who to Test. Sokolova A; Cheng H Oncology (Williston Park); 2021 Oct; 35(10):645-653. PubMed ID: 34669358 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]